Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.
about
Using N-of-1 trials to improve patient management and save costsA comparison of four methods for the analysis of N-of-1 trialsSubmitted for your consideration: potential advantages of a novel clinical trial design and initial patient reactionAggregated N-of-1 trials for unlicensed medicines for small populations: an assessment of a trial with ephedrine for myasthenia gravis.Conducting research in individual patients: lessons learnt from two series of N-of-1 trialsRandomised controlled trials in primary care: scope and application.Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations'N-of-1-pathways' unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine.From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primerReview article: Single subject trials as a research instrument in gastrointestinal pharmacology.Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol.Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.Do pilocarpine drops help dry mouth in palliative care patients: a protocol for an aggregated series of n-of-1 trialsCombined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.Issues in assessing products for the treatment of hemophilia - the intersection between efficacy, economics, and ethics.A CTSA agenda to advance methods for comparative effectiveness research.Understanding Variation in Sets of N-of-1 TrialsExperimental designs for small randomised clinical trials: an algorithm for choice.Efficacy of ultra-micronized palmitoylethanolamide (um-PEA) in geriatric patients with chronic pain: study protocol for a series of N-of-1 randomized trials.What ever happened to N-of-1 trials? Insiders' perspectives and a look to the futureExperimental therapeutics in hereditary neuropathies: the past, the present, and the future.Treatment of neuromuscular channelopathies: current concepts and future prospectsAggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study.Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research.The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Do N-of-1 Trials Need IRB Review?Alternative designs for clinical trials in rare diseases.Single-subject research designs in pediatric rehabilitation: a valuable step towards knowledge translation.Testing pilocarpine drops for dry mouth in advanced cancer using n-of-1 trials: A feasibility study.Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designsA series of N-of-1 trials to assess the therapeutic interchangeability of two enalapril formulations in the treatment of hypertension in Addis Ababa, Ethiopia: study protocol for a randomized controlled trial.Single-patient drug trial methodology for allergic rhinitis.N-of-1 Design and Its Applications to Personalized Treatment Studies.Sample size considerations for n-of-1 trials.The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease.N-of-1 Randomized Trials of Ultra-Micronized Palmitoylethanolamide in Older Patients with Chronic Pain.A series of n-of-1 trials of stimulants in brain injured children.The impact of a computer network on pediatric pain and anxiety: a randomized controlled clinical trial.A New MI-Based Visualization Aided Validation Index for Mining Big Longitudinal Web Trial Data.Personalized (N-of-1) Trials for Depression: A Systematic Review.
P2860
Q24594944-30E88454-DD1F-4F41-8D36-2337DB98C4EFQ28539492-D50D6BCF-1DCE-4375-A170-C4F2216379E5Q28728556-EDB54284-3FC6-4D2F-897D-DA9050EC9D70Q30849110-D2A4957F-3A54-444A-94CF-81C98A50A998Q33258043-A1A3CF4F-56D6-4636-BFB2-42AFDCA14FE3Q34222490-F4D0B348-C001-4110-9DD7-A4F4BBA7FD31Q34238602-07126541-965E-416D-A455-C1ADFDDFD0A6Q34430040-03BACE1B-4871-4040-A49D-80B9F90575ECQ34509675-0B5CF268-84AB-4643-B766-9557989F4A80Q34541690-2F11C47B-3920-49FF-873F-EABF3CB56399Q34687238-AC7258E3-8330-43CF-8EEA-815DCDFC53FDQ34741859-A7262A4E-A2DC-48F4-9E22-270CAC0618F5Q35029512-4B0152CF-6106-4069-9107-5C2DEEB39147Q35532209-5E4161B3-55F0-4392-85B7-4E9CC7A830A6Q35766551-81FA0171-247B-47D7-B01B-327684928BF6Q36054222-522FB2D7-1660-456A-BF2C-FAD68075F916Q36209872-B35240B7-155B-4CB6-A3D5-616D741807A3Q36793954-1A9425BE-2D9A-4A66-A0F4-8707C2F348F0Q37138714-9FAE485D-C5E2-4351-BD87-BC602DD3E54AQ37212198-819B7198-CABE-4416-8240-206191280FBCQ37329508-B6252722-26A5-4C89-AA3A-50DFD92BDA57Q37329554-5FF0117A-5332-4BF7-BF9D-38126FE5818FQ37586413-BC99CBA4-99A9-4C5C-93DA-14F6AD6A423AQ37678444-87F6F110-FA27-418F-890E-3EC352E4F95CQ37892929-59244CF3-99A5-457F-A464-9553F32D4798Q38930102-3E938935-4867-4528-A771-B2483512C6D7Q39013156-E6C726B5-5AF6-434A-8B69-D58438AD2268Q39146276-F81B0FD8-268E-480C-A129-C0C67F91CFCCQ40910978-6976124C-900D-443D-B0CA-D818253E3702Q41450339-3639BC65-2C2D-4E23-8C5C-EA812433EC0AQ42374169-6F3D818C-C75E-42CC-AF47-2C88A631811EQ44114521-81AE9587-E48F-4F1C-9718-97DDFF3E6331Q47154332-4982DAB3-E99E-43CC-8365-C87AA1334F8BQ47189623-BD5524E7-9E5E-484B-8CC9-AC300AD27345Q47557279-DA0D7055-5427-4FA8-8F48-537A12C8D061Q47568634-F9AAF6FE-717A-444A-B3CE-D80F963B4C2CQ48439966-589377B7-D42D-44ED-9F5B-5815AA8B5C0AQ51031379-D66CBDA9-D105-4B37-B196-9B6CFE1E19B2Q51220421-F584B0A1-53A6-481C-A4A8-64691937F69FQ52622441-72DEC168-4237-4566-8DDC-E8C8646CA5AA
P2860
Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Combining single patient (N-of ...... atient responses to treatment.
@en
Combining single patient
@nl
type
label
Combining single patient (N-of ...... atient responses to treatment.
@en
Combining single patient
@nl
prefLabel
Combining single patient (N-of ...... atient responses to treatment.
@en
Combining single patient
@nl
P2093
P1476
Combining single patient (N-of ...... atient responses to treatment.
@en
P2093
P304
P356
10.1016/S0895-4356(96)00429-5
P577
1997-04-01T00:00:00Z